Loading asset research
Calidi Biotherapeutics Inc. Common Stock
CLDINYSE · USD · StocksQuote as of · Exchange session not verified$1.26
+7.69%
Today
CLDI
Loading 1D prices…
Market cap
$3.2M
Volume
189K
52w high
$27.8452w low
$1.05Company profile
Calidi Biotherapeutics Inc. Common Stock
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It also offers oncolytic virus platforms, such as NeuroNova and SuperNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
NYSE
Display currency
USD
Location
SAN DIEGO, CA, United States
Employees
29
Fiscal year end
1231
CIK
1855485
Session & valuation
Open$1.15
Previous close$1.17
Day high$1.29
Day low$1.05
30-day avg. volume98.5K
Outstanding shares2.6M
Diluted EPS-$5.95
Latest annual period
P/E (trailing)-0.21
P/E (forward)-1.36
Price / book0.81
Beta1.32
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2836
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| VIVSVivoSim Labs Inc. Common Stock | $3.5M | $131K | -10567.18% | -$5.35 | +0.54% | Unrated |
| CRISCuris Inc. Common Stock | $2.8M | $9.4M | -80.29% | -$0.58 | -2.68% | Buy |
| LIMNLiminatus Pharma Inc. Class A Common Stock | $4.5M | $0.00 | — | -$0.43 | +1.80% | Unrated |
| PMCBPharmaCyte Biotech Inc. Common Stock | $4.7M | $0.00 | — | -$2.77 | +1.87% | Unrated |
| SLXNSilexion Therapeutics Corp Ordinary Shares | $2M | $0.00 | — | $89.61 | +11.76% | Hold |